Genetic Basis of Inflammatory Airway Disease

炎症性气道疾病的遗传基础

基本信息

  • 批准号:
    7903439
  • 负责人:
  • 金额:
    $ 39.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-27 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objectives of this Career Development Program in the Genetics and Genomics of Lung Diseases entitled "Genetic Basis of Inflammatory Airway Disease" are to develop and evaluate a multidisciplinary program that will educate young pulmonary investigators in methods of genetics and genomics to become independent investigators and assume leadership roles in the genetics and genomics of pulmonary diseases. The central focus of this program, inflammatory airway disease, including asthma, cystic fibrosis, and chronic obstructive pulmonary disease, reflects the importance of understanding diverse, complex pulmonary diseases characterized by airway inflammation and exploits the strong commitment of the faculty at Washington University to apply methods in genetics and genomics to investigation of the biological basis of this family of lung diseases. The first year curriculum will include: 1) the established Genetic Epidemiology Masters of Science (GEMS) Training Program sponsored by the Division of Biostatistics; 2) a mentored research experience to insure submission of a manuscript for publication by the summer of the second year; 3) 3 month educational immersion experiences with established pulmonary and genomic teams of investigators; 4) relevant, ongoing conferences, journal clubs, lectures, and courses; and, 5) the NHLBI sponsored Programs for Genomic Applications Traveling Tutorial. The second and third year curriculum will include: 1) continuation of the mentored research experience; 2) additional courses; and, 3) submission of a K Award application. The specific aims of this application include: Specific Aim (1): We will provide fundamental training in genetic epidemiology and biostatistics with emphasis on translational research. Specific Aim (2): We will provide extensive mentoring to the trainees for career development and for developing independent research plans that focus on pulmonary disorders. Specific Aim (3): We will support trainees by helping them prepare independent career development research grants such as KO8 and K23 Awards and by taking full advantage of the extraordinary resources of the participating mentors and institutional environment. Specific Aim (4): We will develop and implement plans for evaluating and tracking the effectiveness and success of these efforts for each trainee up to 2 years after completion of the program. This career development program will train young scientists to use state of the art methods in genetics and genomics to develop new diagnostic and therapeutic strategies for asthma, cystic fibrosis, and COPD. (End of Abstract)
描述(由申请人提供): 《肺部疾病遗传学和基因组学》的这一职业发展计划的目标是开发和评估一个多学科计划,该计划将教育年轻的肺部研究人员遗传学和基因组学方法,使其成为独立的研究人员,并在肺部疾病的遗传学和基因组学方面担任领导角色。该项目的中心焦点是炎症性呼吸道疾病,包括哮喘、囊性纤维化和慢性阻塞性肺疾病,反映了了解以呼吸道炎症为特征的各种复杂肺部疾病的重要性,并利用华盛顿大学教职员工的坚定承诺,应用遗传学和基因组学方法来研究这类肺部疾病的生物学基础。第一年的课程将包括:1)由生物统计司赞助的遗传流行病学科学硕士(GEMS)培训计划;2)指导研究经验,以确保在第二年夏天之前提交手稿发表;3)3个月与现有的肺部和基因组研究团队的教育沉浸经历;4)相关的、正在进行的会议、杂志俱乐部、讲座和课程;以及5)NHLBI赞助的基因组应用旅行教程计划。第二和第三年的课程将包括:1)继续指导研究经验;2)附加课程;以及3)提交K奖申请。这一应用的具体目标包括:具体目标(1):我们将提供遗传流行病学和生物统计学的基础培训,重点是翻译研究。具体目标(2):我们将为受训者提供广泛的职业发展指导,并制定专注于肺部疾病的独立研究计划。具体目标(3):我们将通过帮助学员准备独立的职业发展研究补助金,如KO8和K23奖,并充分利用参与导师的非凡资源和机构环境来支持学员。具体目标(4):我们将制定和实施计划,以评估和跟踪每个受训人员在计划完成后两年内这些努力的有效性和成功。这一职业发展计划将培训年轻科学家使用遗传学和基因组学中最先进的方法来开发哮喘、囊性纤维化和慢性阻塞性肺病的新诊断和治疗策略。 (摘要结束)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Francis Sessions Cole其他文献

Francis Sessions Cole的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Francis Sessions Cole', 18)}}的其他基金

Clinical Research Support Core
临床研究支持核心
  • 批准号:
    10682166
  • 财政年份:
    2023
  • 资助金额:
    $ 39.66万
  • 项目类别:
Washington University School of Medicine Undiagnosed Diseases Network Clinical Site
华盛顿大学医学院未确诊疾病网络临床站点
  • 批准号:
    9789913
  • 财政年份:
    2018
  • 资助金额:
    $ 39.66万
  • 项目类别:
Washington University School of Medicine Undiagnosed Diseases Network Clinical Site
华盛顿大学医学院未确诊疾病网络临床站点
  • 批准号:
    9977220
  • 财政年份:
    2018
  • 资助金额:
    $ 39.66万
  • 项目类别:
Lipidomic Screening For Functional Surfactant Gene Mutations
功能性表面活性剂基因突变的脂质组学筛选
  • 批准号:
    9021312
  • 财政年份:
    2014
  • 资助金额:
    $ 39.66万
  • 项目类别:
Lipidomic Screening For Functional Surfactant Gene Mutations
功能性表面活性剂基因突变的脂质组学筛选
  • 批准号:
    8606976
  • 财政年份:
    2014
  • 资助金额:
    $ 39.66万
  • 项目类别:
Genetic Regulation of Surfactant Deficiency
表面活性剂缺乏的基因调控
  • 批准号:
    7824722
  • 财政年份:
    2009
  • 资助金额:
    $ 39.66万
  • 项目类别:
Genetic Regulation of Surfactant Deficiency
表面活性剂缺乏的基因调控
  • 批准号:
    7588777
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Genetic Basis of Inflammatory Airway Disease
炎症性气道疾病的遗传基础
  • 批准号:
    7323914
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Genetic Regulation of Surfactant Deficiency
表面活性剂缺乏的基因调控
  • 批准号:
    7828089
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Genetic Basis of Inflammatory Airway Disease
炎症性气道疾病的遗传基础
  • 批准号:
    7664316
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:

相似海外基金

Testing the effectiveness of the biological drug, Tezepelumab, in patients with coexisting allergic rhinitis and allergic asthma
测试生物药物 Tezepelumab 对同时患有过敏性鼻炎和过敏性哮喘的患者的有效性
  • 批准号:
    490921
  • 财政年份:
    2022
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Studentship Programs
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
  • 批准号:
    10396626
  • 财政年份:
    2021
  • 资助金额:
    $ 39.66万
  • 项目类别:
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
  • 批准号:
    10216007
  • 财政年份:
    2021
  • 资助金额:
    $ 39.66万
  • 项目类别:
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
  • 批准号:
    10615633
  • 财政年份:
    2021
  • 资助金额:
    $ 39.66万
  • 项目类别:
Sex as a biological variable: Immunomodulatory mechanisms of Innate Defence Regulator (IDR) peptides in asthma
性别作为生物变量:先天防御调节剂 (IDR) 肽在哮喘中的免疫调节机制
  • 批准号:
    449782
  • 财政年份:
    2020
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Studentship Programs
Potential biological mechanisms with regard to the association betwen asthma and obesity
哮喘与肥胖之间关联的潜在生物学机制
  • 批准号:
    17K09599
  • 财政年份:
    2017
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
  • 批准号:
    7434307
  • 财政年份:
    2008
  • 资助金额:
    $ 39.66万
  • 项目类别:
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
  • 批准号:
    8092713
  • 财政年份:
    2008
  • 资助金额:
    $ 39.66万
  • 项目类别:
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
  • 批准号:
    7685408
  • 财政年份:
    2008
  • 资助金额:
    $ 39.66万
  • 项目类别:
Socioeconomic Status, Stress & Asthma Biological Markers
社会经济地位、压力
  • 批准号:
    7477093
  • 财政年份:
    2005
  • 资助金额:
    $ 39.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了